- Home
- CQP vs LSBPW Comparison
CQP vs LSBPW Comparison
Compare CQP & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CQP
- LSBPW
- Stock Information
- Founded
- CQP 2003
- LSBPW N/A
- Country
- CQP United States
- LSBPW China
- Employees
- CQP N/A
- LSBPW 758
- Industry
- CQP Oil/Gas Transmission
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- CQP Utilities
- LSBPW Health Care
- Exchange
- CQP Nasdaq
- LSBPW Nasdaq
- Market Cap
- CQP N/A
- LSBPW N/A
- IPO Year
- CQP 2007
- LSBPW N/A
- Fundamental
- Price
- CQP $53.03
- LSBPW $0.04
- Analyst Decision
- CQP Sell
- LSBPW
- Analyst Count
- CQP 3
- LSBPW 0
- Target Price
- CQP $47.00
- LSBPW N/A
- AVG Volume (30 Days)
- CQP 172.0K
- LSBPW N/A
- Earning Date
- CQP 10-31-2024
- LSBPW N/A
- Dividend Yield
- CQP 6.11%
- LSBPW N/A
- EPS Growth
- CQP N/A
- LSBPW N/A
- EPS
- CQP 4.62
- LSBPW N/A
- Revenue
- CQP $8,930,000,000.00
- LSBPW N/A
- Revenue This Year
- CQP N/A
- LSBPW N/A
- Revenue Next Year
- CQP $13.64
- LSBPW N/A
- P/E Ratio
- CQP $11.47
- LSBPW N/A
- Revenue Growth
- CQP N/A
- LSBPW N/A
- 52 Week Low
- CQP $45.51
- LSBPW N/A
- 52 Week High
- CQP $62.34
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- CQP 67.68
- LSBPW N/A
- Support Level
- CQP $49.26
- LSBPW N/A
- Resistance Level
- CQP $50.85
- LSBPW N/A
- Average True Range (ATR)
- CQP 1.11
- LSBPW 0.00
- MACD
- CQP 0.36
- LSBPW 0.00
- Stochastic Oscillator
- CQP 95.45
- LSBPW 0.00
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.